Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 ~2x weekly·147 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHosts
Not detected.
Recent guests
Recent episodes
Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME Initiative
Jun 9, 2026
21m 06s
Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge
Jun 5, 2026
18m 45s
Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer
Jun 5, 2026
19m 41s
Marwan Fakih, MD - Making a Difference in Refractory Metastatic Colorectal Cancer: Practical Strategies to Positively Impact the Patient Journey Across Practice Settings
May 26, 2026
28m 23s
Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer
May 26, 2026
54m 23s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/9/26 | Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME Initiative✨ | bladder cancermultidisciplinary team+3 | Andrea Necchi, MD | — | — | bladder cancerCME+3 | — | 21m 06s | |
| 6/5/26 | Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge✨ | Surgical InterventionsSystemic Innovations+3 | Silvia Stacchiotti, MDMichiel van de Sande, MD, PhD | PeerVoice | — | Tenosynovial Giant Cell Tumoursurgical interventions+3 | — | 18m 45s | |
| 6/5/26 | Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer✨ | TROP2-Directed ADCsAdvanced Breast Cancer+3 | Javier Cortés, MD, PhDLaura Huppert, MD | — | — | TROP2ADCs+3 | — | 19m 41s | |
| 5/26/26 | Marwan Fakih, MD - Making a Difference in Refractory Metastatic Colorectal Cancer: Practical Strategies to Positively Impact the Patient Journey Across Practice Settings✨ | refractory metastatic colorectal cancerpatient journey+3 | Marwan Fakih, MD | — | — | colorectal cancermetastatic cancer+3 | — | 28m 23s | |
| 5/26/26 | Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer✨ | head and neck cancerrecurrent cancer+3 | Trisha Wise-Draper, MD, PhD | — | — | head and neck cancerrecurrent cancer+3 | — | 54m 23s | |
| 5/18/26 | Martin Köbel, MD - Scoring Folate Receptor-Alpha Expression in Gynecological Cancers: An Interactive Pathology Masterclass✨ | Folate Receptor-AlphaGynecological Cancers+3 | Martin Köbel, MD | — | — | Folate Receptor-Alphagynecological cancers+3 | — | 29m 59s | |
| 3/25/26 | Austin Kulasekararaj, MD, MRCP, FRCPath - From Life-Threatening to Life-Optimised: The Evolving Management of Paroxysmal Nocturnal Haemoglobinuria Across the Complement Cascade✨ | Paroxysmal Nocturnal HaemoglobinuriaComplement Cascade+3 | Austin Kulasekararaj, MD, MRCP, FRCPath | — | — | Paroxysmal Nocturnal HaemoglobinuriaComplement Cascade+3 | — | 29m 29s | |
| 3/25/26 | Pier Luigi Zinzani, MD, PhD - Recognising and Responding to a Rare Disease: A Case-Based Exploration of the Ideal iMCD Patient Journey✨ | rare diseaseiMCD+4 | Pier Luigi Zinzani, MD, PhD | — | — | iMCDrare disease+3 | — | 20m 07s | |
| 3/6/26 | Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era✨ | SCLC treatmentimmunotherapy+3 | Jonathan W. Goldman, MDMisty Dawn Shields, MD, PhD | PeerVoice | — | SCLCimmunotherapy+3 | — | 40m 01s | |
| 2/25/26 | Matthew J. Koster, MD - VEXAS Syndrome Asked and Answered: Everything You Want To Know And More✨ | VEXAS Syndromemedical education+3 | Matthew J. Koster, MD | — | — | VEXAS SyndromeMatthew J. Koster+4 | — | 28m 24s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/25/26 | Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?✨ | HER2-Positive Metastatic Breast CancerFirst-Line Treatment+4 | Cristina Saura Manich, MD, PhD | — | — | HER2-PositiveMetastatic Breast Cancer+5 | — | 19m 34s | |
| 1/7/26 | Rebecca Dent, MD, FRCP (Canada) - TROP2 and Triple-Negative Breast Cancer: The Rationale and Emerging Evidence for Exploring the Therapeutic Potential of TROP2-Targeted Antibody-Drug Conjugates in Earlier Lines and Disease-Stage Settings✨ | TROP2Triple-Negative Breast Cancer+3 | Rebecca Dent, MD, FRCP | TROP2-Targeted Antibody-Drug ConjugatesCanada | — | TROP2Triple-Negative Breast Cancer+3 | — | 21m 47s | |
| 12/17/25 | Francesco Passamonti, MD - Myelofibrosis Under the Microscope: Exploring p53 Dysregulation as a Potential Therapeutic Target✨ | Myelofibrosisp53 Dysregulation+3 | Francesco Passamonti, MD | — | — | Myelofibrosisp53+4 | — | 19m 41s | |
| 12/17/25 | Steven Horwitz, MD - Relapsed/Refractory Peripheral T-Cell Lymphoma: Reviewing Available and Anticipated Strategies in This Rare Malignancy | Steven Horwitz, MD - Relapsed/Refractory Peripheral T-Cell Lymphoma: Reviewing Available and Anticipated Strategies in This Rare Malignancy | — | ||||||
| 11/8/25 | Sanjay Popat, FRCP, PhD - Don’t Forget About HER2: Clinical Insights and Novel Therapies for HER2-Mutant NSCLC From ESMO 2025 | Sanjay Popat, FRCP, PhD - Don’t Forget About HER2: Clinical Insights and Novel Therapies for HER2-Mutant NSCLC From ESMO 2025 | — | ||||||
| 10/30/25 | Nadia Harbeck, MD, PhD - Antibody-Drug Conjugates in Breast Cancer: Keeping Abreast of the Latest Data As They Emerge From ESMO | Nadia Harbeck, MD, PhD - Antibody-Drug Conjugates in Breast Cancer: Keeping Abreast of the Latest Data As They Emerge From ESMO | — | ||||||
| 10/30/25 | Fred Saad, MD, FRCS - From Platform to Practice: Insights From ESMO 2025 on the Latest Data Guiding Contemporary Care in mHSPC and nmCRPC | Fred Saad, MD, FRCS - From Platform to Practice: Insights From ESMO 2025 on the Latest Data Guiding Contemporary Care in mHSPC and nmCRPC | — | ||||||
| 10/8/25 | Naveen Pemmaraju, MD - How I Treat BPDCN: A Case-Based Exploration of Best Practices in Selecting and Providing Therapeutic Strategies | Naveen Pemmaraju, MD - How I Treat BPDCN: A Case-Based Exploration of Best Practices in Selecting and Providing Therapeutic Strategies | — | ||||||
| 10/3/25 | Solange Peters, MD, PhD - Pioneering Precision: A Real-World Roadmap to Optimal Outcomes in NTRK Fusion-Positive and HER2-Mutant Advanced NSCLC | Solange Peters, MD, PhD - Pioneering Precision: A Real-World Roadmap to Optimal Outcomes in NTRK Fusion-Positive and HER2-Mutant Advanced NSCLC | — | ||||||
| 10/1/25 | Alicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With Patients | Alicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With Patients | — | ||||||
| 8/20/25 | Neal Shore, MD, FACS - Redefining Expectations in mHSPC: Options and Opportunities Across the Spectrum of Disease | Neal Shore, MD, FACS - Redefining Expectations in mHSPC: Options and Opportunities Across the Spectrum of Disease | — | ||||||
| 8/19/25 | Enriqueta Felip, MD, PhD - Targeting TROP2 in Advanced NSCLC: What Do We Know From Recent Clinical Trials? | Enriqueta Felip, MD, PhD - Targeting TROP2 in Advanced NSCLC: What Do We Know From Recent Clinical Trials? | — | ||||||
| 8/19/25 | Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making | Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making | — | ||||||
| 7/21/25 | Solange Peters, MD, PhD - Partnering With Patients: Shared Decision-Making in Locally Advanced, Unresectable EGFR-Mutated Non-Small Cell Lung Cancer | Solange Peters, MD, PhD - Partnering With Patients: Shared Decision-Making in Locally Advanced, Unresectable EGFR-Mutated Non-Small Cell Lung Cancer | — | ||||||
Showing 24 of 153
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.